S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.12

Oaktree Specialty Lending Stock Forecast, Price & News

-0.04 (-0.54 %)
(As of 10/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume449,387 shs
Average Volume789,746 shs
Market Capitalization$1.33 billion
P/E Ratio4.05
Dividend Yield7.82%
30 days | 90 days | 365 days | Advanced Chart
Receive OCSL News and Ratings via Email

Sign-up to receive the latest news and ratings for Oaktree Specialty Lending and its competitors with MarketBeat's FREE daily newsletter.

Oaktree Specialty Lending logo

About Oaktree Specialty Lending

Oaktree Specialty Lending Corp. is a specialty finance company, which engages in the provision of customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. Its portfolio include first lien, second lien, kemper jv, and equity. The company was founded on February 15, 2007 and is headquartered in Los Angeles, CA with an investment size of $10 m to $100 m and an EBITDA of $25 m to $250 m.


See More Headlines

Industry, Sector and Symbol

Personal credit institutions
Asset Management & Custody Banks
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$143.13 million
Cash Flow
$0.53 per share
Book Value
$6.49 per share


Net Income
$39.22 million




Market Cap
$1.33 billion
Next Earnings Date
11/16/2021 (Confirmed)


Overall MarketRank

2.29 out of 5 stars

Finance Sector

380th out of 1,338 stocks

Personal Credit Institutions Industry

8th out of 13 stocks

Analyst Opinion: 1.5Community Rank: 4.1Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -

Oaktree Specialty Lending (NASDAQ:OCSL) Frequently Asked Questions

Is Oaktree Specialty Lending a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Oaktree Specialty Lending in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Oaktree Specialty Lending stock.
View analyst ratings for Oaktree Specialty Lending
or view top-rated stocks.

What stocks does MarketBeat like better than Oaktree Specialty Lending?

Wall Street analysts have given Oaktree Specialty Lending a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Oaktree Specialty Lending wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Oaktree Specialty Lending's next earnings date?

Oaktree Specialty Lending is scheduled to release its next quarterly earnings announcement on Tuesday, November 16th 2021.
View our earnings forecast for Oaktree Specialty Lending

How can I listen to Oaktree Specialty Lending's earnings call?

Oaktree Specialty Lending will be holding an earnings conference call on Tuesday, November 16th at 1:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "10160823".

How were Oaktree Specialty Lending's earnings last quarter?

Oaktree Specialty Lending Co. (NASDAQ:OCSL) released its quarterly earnings results on Thursday, August, 5th. The credit services provider reported $0.19 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.14 by $0.05. The credit services provider earned $65.44 million during the quarter, compared to analysts' expectations of $50.69 million. Oaktree Specialty Lending had a net margin of 143.41% and a trailing twelve-month return on equity of 8.87%.
View Oaktree Specialty Lending's earnings history

How has Oaktree Specialty Lending's stock been impacted by Coronavirus?

Oaktree Specialty Lending's stock was trading at $4.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OCSL shares have increased by 66.2% and is now trading at $7.38.
View which stocks have been most impacted by COVID-19

How often does Oaktree Specialty Lending pay dividends? What is the dividend yield for Oaktree Specialty Lending?

Oaktree Specialty Lending announced a quarterly dividend on Thursday, August 5th. Shareholders of record on Wednesday, September 15th will be given a dividend of $0.145 per share on Thursday, September 30th. This represents a $0.58 annualized dividend and a dividend yield of 7.86%. The ex-dividend date is Tuesday, September 14th. This is a boost from Oaktree Specialty Lending's previous quarterly dividend of $0.13.
View Oaktree Specialty Lending's dividend history

Is Oaktree Specialty Lending a good dividend stock?

Oaktree Specialty Lending pays an annual dividend of $0.58 per share and currently has a dividend yield of 7.82%. OCSL has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Oaktree Specialty Lending has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Oaktree Specialty Lending is 113.73%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Oaktree Specialty Lending will have a dividend payout ratio of 92.06% in the coming year. This indicates that Oaktree Specialty Lending may not be able to sustain their current dividend.
View Oaktree Specialty Lending's dividend history.

What price target have analysts set for OCSL?

3 equities research analysts have issued 1 year price targets for Oaktree Specialty Lending's shares. Their forecasts range from $7.25 to $8.00. On average, they expect Oaktree Specialty Lending's share price to reach $7.58 in the next twelve months. This suggests a possible upside of 2.8% from the stock's current price.
View analysts' price targets for Oaktree Specialty Lending
or view top-rated stocks among Wall Street analysts.

Who are Oaktree Specialty Lending's key executives?

Oaktree Specialty Lending's management team includes the following people:
  • Armen Panossian, Chief Executive & Investment Officer
  • Matt Pendo, President & Chief Operating Officer
  • Mel Carlisle, Chief Financial Officer & Treasurer
  • Kimberly Larin, Chief Compliance Officer
  • Brian Thomas Walter, Managing Director & Head-Institutional Products

What other stocks do shareholders of Oaktree Specialty Lending own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oaktree Specialty Lending investors own include Prospect Capital (PSEC), Energy Transfer (ET), AGNC Investment (AGNC), Annaly Capital Management (NLY), Ready Capital (RC), Ares Capital (ARCC), AT&T (T), PennantPark Investment (PNNT), PhenixFIN (MCC) and New Residential Investment (NRZ).

What is Oaktree Specialty Lending's stock symbol?

Oaktree Specialty Lending trades on the NASDAQ under the ticker symbol "OCSL."

Who are Oaktree Specialty Lending's major shareholders?

Oaktree Specialty Lending's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Waverton Investment Management Ltd (0.81%), Blue Zone Wealth Advisors LLC (0.52%), Sumitomo Mitsui Trust Holdings Inc. (0.51%), TCW Group Inc. (0.37%), Epiq Partners LLC (0.34%) and Rezny Wealth Management Inc. (0.33%). Company insiders that own Oaktree Specialty Lending stock include Armen Panossian, Craig A Jacobson, Deborah Ann Gero, Leonard M Tannenbaum, Leonard M Tannenbaum, Mathew Pendo, Melvin Carlisle and Richard Ruben.
View institutional ownership trends for Oaktree Specialty Lending

Which institutional investors are selling Oaktree Specialty Lending stock?

OCSL stock was sold by a variety of institutional investors in the last quarter, including TCW Group Inc., Sumitomo Mitsui Trust Holdings Inc., RMB Capital Management LLC, FNY Investment Advisers LLC, and Atlas Private Wealth Advisors.
View insider buying and selling activity for Oaktree Specialty Lending
or view top insider-selling stocks.

Which institutional investors are buying Oaktree Specialty Lending stock?

OCSL stock was acquired by a variety of institutional investors in the last quarter, including Rezny Wealth Management Inc., Waverton Investment Management Ltd, Carnegie Capital Asset Management LLC, Blue Zone Wealth Advisors LLC, Total Clarity Wealth Management Inc., DNB Asset Management AS, GPS Wealth Strategies Group LLC, and Epiq Partners LLC. Company insiders that have bought Oaktree Specialty Lending stock in the last two years include Armen Panossian, Craig A Jacobson, Deborah Ann Gero, Mathew Pendo, Melvin Carlisle, and Richard Ruben.
View insider buying and selling activity for Oaktree Specialty Lending
or or view top insider-buying stocks.

How do I buy shares of Oaktree Specialty Lending?

Shares of OCSL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Oaktree Specialty Lending's stock price today?

One share of OCSL stock can currently be purchased for approximately $7.38.

How much money does Oaktree Specialty Lending make?

Oaktree Specialty Lending has a market capitalization of $1.33 billion and generates $143.13 million in revenue each year. The credit services provider earns $39.22 million in net income (profit) each year or $0.51 on an earnings per share basis.

What is Oaktree Specialty Lending's official website?

The official website for Oaktree Specialty Lending is www.oaktreespecialtylending.com.

Where are Oaktree Specialty Lending's headquarters?

Oaktree Specialty Lending is headquartered at 333 SOUTH GRAND AVENUE 28TH FLOOR, LOS ANGELES CA, 90071.

How can I contact Oaktree Specialty Lending?

Oaktree Specialty Lending's mailing address is 333 SOUTH GRAND AVENUE 28TH FLOOR, LOS ANGELES CA, 90071. The credit services provider can be reached via phone at (213) 830-6300 or via email at [email protected].

This page was last updated on 10/27/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.